Genmab — Februar 2017
-
Tusinde tak for link Davor.
-
Eni
g Solsen. -
Ja og selv om nogle er skeptiske overfor Winkels evige optimisme, så er han nok bare utålmodig - som "et barn" - hvis man kan bruge sådant et udtryk. Indtil nu har han haft ret i stort set alt, stort set, og han ønsker bare brændende at han kunne dele sin viden med andre.
-
Recently I spoke with two experts in the field (biotech investors with biotech experience at board level) who believed Dara in combo I/O studies could be approved after phase 1/2 if the data is overwhelmingly positive and of course save. Just like Dara/PomM/Dex. I'm not an expert regarding the regulation so I’m not 100% sure this is true but if true than it could all move very fast and the stock price will probably already implement a big chunk of the future prognosed value when strong
-
when strong data comes out.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind